Author

N. D. Ebelt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. R. Manuel· 2 shared A. Iniguez· 1 shared B. R. Blazar· 1 shared D. J. Diamond· 1 shared E. Zuniga· 1 shared F. Chiuppesi· 1 shared F. Wussow· 1 shared H. Contreras· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. R. Manuel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Restructuring of the Immune Contexture Improves Checkpoint Blockade Efficacy in Murine Lung Cancer

N. D. Ebelt, E. Zuniga, M. Marzagalli, V. Zamloot, B. R. Blazar, R. Salgia, E. R. Manuel

This study shows that altering the tumor immune landscape with shIDO-ST improves checkpoint blockade efficacy in murine lung cancer by enhancing antigen presentation and reducing suppressive immune cells.

bioRxiv · Oct 9, 2020 · PreprintCancer Biology

Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine

F. Chiuppesi, M. S. Werner, H. Contreras, H. V. Nguyen, J. Martinez, S. Park, J. Nguyen, M. Kha, A. Iniguez, Q. Zhou, T. Kaltcheva, R. Levytskyy, N. D. Ebelt, T. H. Kang, X. Wu, , F. Wussow

This paper develops a synthetic DNA-based vaccine platform to rapidly generate SARS-CoV-2 vaccines using recombinant MVA vectors expressing spike and nucleocapsid antigens, showing robust immune responses in mice.

bioRxiv · Jul 1, 2020 · PreprintImmunology